KUALA LUMPUR (Oct 13): Macquarie analyst Anand Pathmakanthan downgraded the recommendation on IHH Healthcare Bhd to neutral from outperform.
Pathmakanthan lowered the target price to RM6.10 from RM6.70, implying a 5.7 percent increase from the last close. The target is 4.6 percent below the consensus average of RM6.40. IHH Healthcare had 10 buy recommendations, 12
holds and 2 sells before today.
Investors who followed Pathmakanthan's recommendation would have received a negative 9.3 percent return in the past year before today, the same as the company's performance.
Analysts lowered their consensus one-year target price for the stock by 2.2 percent in the past three months. Forecasts range from RM5.08
to RM7.20.
Pathmakanthan covers 12 companies; 1 is rated underperform, 5 are rated outperform, 5 are rated neutral and 1 is rated suspended coverage.